Report cover image

Global Hematology Diagnostics Market Growth, Size, Trends Analysis - By Product, By Test Type, By Modality, By Application, By End Use- Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Published Jun 10, 2025
Length 222 Pages
SKU # SPER20190586

Description

Hematology Diagnostics Market Introduction and Overview

According to SPER market research, ‘Global Hematology Diagnostics Market Size- By Product, By Test Type, By Modality, By Application, By End Use – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Hematology Diagnostics Market is predicted to reach 7.88 billion by 2034 with a CAGR of 6.86%.

Hematology diagnostics, which focuses on the study, identification, and monitoring of disorders involving blood and its components, including red blood cells, white blood cells, platelets, hemoglobin, blood proteins, and coagulation mechanisms, is an essential field of medical diagnostics. This field is crucial for the diagnosis and treatment of a wide range of diseases, such as anemia, leukemia, lymphoma, hemophilia, and infections.

Restraints:Despite its potential for expansion, the global hematology diagnostics market faces a number of formidable obstacles. One of the primary obstacles to the adoption of advanced diagnostic tools and supplies in low- and middle-income countries is their high cost. This is exacerbated by the inadequate healthcare infrastructure and laboratory capacity in these areas, which restrict access to timely and accurate diagnostics.

Scope of the report:

Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034

Segments covered

By Product, By Test Type, By Modality, By Application, By End Use

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered

Abbott, BAG Diagnostics, Beckman Coulter, Bio-Rad, BioSystems, Boule, Diatron, HemoCue, HORIBA Medical, Mindray

Global Hematology Diagnostics Market Segmentation:

By Product:
Based on the Product, Global Hematology Diagnostics Market is segmented as; Reagents and Consumables, Instruments.

By Test Type:Based on the Test Type, Global Hematology Diagnostics Market is segmented as; Complete Blood Count (CBC) Test, Platelet Function Test, Hemoglobin Test, Hematocrit Test, Other Test Types.

By Modality:Based on the Modality, Global Hematology Diagnostics Market is segmented as; Laboratory-Based Testing, Point-of-care (POC) Testing.

By Application:Based on the Application, Global Hematology Diagnostics Market is segmented as; Oncology, Anemia, Infectious Diseases, Cardiovascular Disorders, Other Applications.

By End Use:Based on the End Use, Global Hematology Diagnostics Market is segmented as; Hospitals, Diagnostic Laboratories, Other End Users.

By Region:This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

222 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Hematology Diagnostics Market Size Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Hematology Diagnostics Market
7. Global Hematology Diagnostics Market, By Product 2021-2034 (USD Million)
7.1. Reagents and Consumables
7.2. Instruments
8. Global Hematology Diagnostics Market, By Test Type 2021-2034 (USD Million)
8.1. Complete Blood Count (CBC) Test
8.2. Platelet Function Test
8.3. Hemoglobin Test
8.4. Hematocrit Test
8.5. Other Test Types
9. Global Hematology Diagnostics Market, By Modality 2021-2034 (USD Million)
9.1. Laboratory-based Testing
9.2. Point-of-care (POC) Testing
10. Global Hematology Diagnostics Market, By Application 2021-2034 (USD Million)
10.1. Oncology
10.2. Anemia
10.3. Infectious Diseases
10.4. Cardiovascular Disorders
10.5. Other Applications
11. Global Hematology Diagnostics Market, By End-Use 2021-2034 (USD Million)
11.1. Hospitals
11.2. Diagnostic Laboratories
11.3. Other End Users
12. Global Hematology Diagnostics Market 2021-2034 (USD Million)
12.1. Global Hematology Diagnostics Market Size and Market Share
13. Global Hematology Diagnostics Market, By Region, 2021-2034 (USD Million)
13.1. Asia-Pacific
13.1.1. Australia
13.1.2. China
13.1.3. India
13.1.4. Japan
13.1.5. South Korea
13.1.6. Rest of Asia-Pacific
13.2. Europe
13.2.1. France
13.2.2. Germany
13.2.3. Italy
13.2.4. Spain
13.2.5. United Kingdom
13.2.6. Rest of Europe
13.3. Middle East and Africa
13.3.1. Kingdom of Saudi Arabia
13.3.2. United Arab Emirates
13.3.3. Qatar
13.3.4. South Africa
13.3.5. Egypt
13.3.6. Morocco
13.3.7. Nigeria
13.3.8. Rest of Middle-East and Africa
13.4. North America
13.4.1. Canada
13.4.2. Mexico
13.4.3. United States
13.5. Latin America
13.5.1. Argentina
13.5.2. Brazil
13.5.3. Rest of Latin America
14. Company Profile
14.1. Abbott
14.1.1. Company details
14.1.2. Financial outlook
14.1.3. Product summary
14.1.4. Recent developments
14.2. BAG Diagnostics
14.2.1. Company details
14.2.2. Financial outlook
14.2.3. Product summary
14.2.4. Recent developments
14.3. Beckman Coulter
14.3.1. Company details
14.3.2. Financial outlook
14.3.3. Product summary
14.3.4. Recent developments
14.4. Bio-Rad
14.4.1. Company details
14.4.2. Financial outlook
14.4.3. Product summary
14.4.4. Recent developments
14.5. BioSystems
14.5.1. Company details
14.5.2. Financial outlook
14.5.3. Product summary
14.5.4. Recent developments
14.6. Boule
14.6.1. Company details
14.6.2. Financial outlook
14.6.3. Product summary
14.6.4. Recent developments
14.7. Diatron
14.7.1. Company details
14.7.2. Financial outlook
14.7.3. Product summary
14.7.4. Recent developments
14.8. HemoCue
14.8.1. Company details
14.8.2. Financial outlook
14.8.3. Product summary
14.8.4. Recent developments
14.9. HORIBA Medical
14.9.1. Company details
14.9.2. Financial outlook
14.9.3. Product summary
14.9.4. Recent developments
14.10. Mindray
14.10.1. Company details
14.10.2. Financial outlook
14.10.3. Product summary
14.10.4. Recent developments
14.11. Others
15. Conclusion
16. List of Abbreviations
17. Reference Links
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.